Open Access Pre-publication history

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I

Afsar Ali Mian, Anna Metodieva, Susanne Badura, Mamduh Khateb, Nili Ruimi, Yousef Najajreh, Oliver Gerhard Ottmann, Jamal Mahajna and Martin Ruthardt*

BMC Cancer 2012, 12:411  doi:10.1186/1471-2407-12-411

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 13 Apr 2012
Reviewer's Report Oliver Hantschel 01 Jun 2012
Reviewer's Report Seiichi Okabe 05 Jun 2012
Resubmission - Version 2 Manuscript Author's comment 16 Jul 2012
Reviewer's Report Seiichi Okabe 01 Aug 2012
Resubmission - Version 3 Manuscript Author's comment 23 Aug 2012
Editorial acceptance 31 Aug 2012
Published 17 Sep 2012